Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
Frontiers in Cell and Developmental Biology · 05.01.2024 · 11
DOI: 10.3389/fcell.2023.1327466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 05.01.2024. Verfasst von Jin-He Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Yinfeng Academy of Life Science, Jinan, Shandong, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blood has an important role in the healthcare system, particularly in blood transfusions and immunotherapy. However, the occurrence of outbreaks of infectious diseases worldwide and seasonal fluctuations, blood shortages are becoming a major challenge. Moreover, the narrow specificity of immune cells hinders the widespread application of immune cell therapy. To address this issue, researchers are actively developing strategies for differentiating induced pluripotent stem cells (iPSCs) into blood cells in vitro . The establishment of iPSCs from terminally differentiated cells such as fibroblasts and blood cells is a straightforward process. However, there is need for further refinement of the protocols for differentiating iPSCs into immune cells and red blood cells to ensure their clinical applicability. This review aims to provide a comprehensive overview of the strategies and challenges facing the generation of iPSC-derived immune cells and red blood cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Yinfeng Academy of Life Science, Jinan, Shandong, China.
- Institute of Biomedical and Health Science, School of Life and Health Science, Anhui Science and Technology University, Chuzhou, Anhui, China.
Zitieren
APA
Jiang, J. H., Ren, R. T., Cheng, Y. J., Li, X. X., & Zhang, G. R. (2024). Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1327466
Vancouver
Jiang JH, Ren RT, Cheng YJ, Li XX, Zhang GR. Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges. Frontiers in Cell and Developmental Biology. 2024;11. doi:10.3389/fcell.2023.1327466
BibTeX
@article{Jiang2024,
author = {Jiang, Jin-He and Ren, Ru-Tong and Cheng, Yan-Jie and Li, Xin-Xin and Zhang, Gui-Rong},
title = {Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges},
journal = {Frontiers in Cell and Developmental Biology},
year = {2024},
volume = {11},
doi = {10.3389/fcell.2023.1327466}
}
EUVIMED